Zimmer Biomet Holdings (ZBH) FCF Payout Ratio Growth (3y) (2015 - 2026)
Zimmer Biomet Holdings (ZBH) FCF Payout Ratio Growth (3y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Cover Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn | 0.91% |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn | -3.43% |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn | -18.36% |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn | - |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn | - |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn | - |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn | - |
| 10 | Zimmer Biomet Holdings | 17.27 Bn | 16.86 Bn | 1.51 Bn | -9.02% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -9.02% |
| Dec 31, 2025 | -27.25% |
| Sep 30, 2025 | 1.57% |
| Jun 30, 2025 | -4.29% |
| Mar 31, 2025 | -7.70% |
| Dec 31, 2024 | -15.36% |
| Sep 30, 2024 | 2.06% |
| Jun 30, 2024 | 7.16% |
| Mar 31, 2024 | 4.29% |
| Dec 31, 2023 | -19.29% |
| Sep 30, 2023 | 11.83% |
| Jun 30, 2023 | 31.82% |
| Mar 31, 2023 | 16.94% |
| Dec 31, 2022 | 27.98% |
| Sep 30, 2022 | 9.57% |
| Jun 30, 2022 | -6.62% |
| Mar 31, 2022 | -3.39% |
| Dec 31, 2021 | 5.65% |
| Sep 30, 2021 | 4.50% |
| Jun 30, 2021 | -1.64% |